Blog | Ryon Graf

Ryon

Precision Oncology Needs Neoadjuvant Clinical Trials like I-SPY2

4 March 2014 The emerging view of cancer is an increasingly diverse set of rare diseases with overlapping etiology and molecular drivers...

Ryon

New Publication, Dissertation Approved, and Histology

18 February 2014 It’s been a busy month! Well, most months are busy, but this one has been especially so, and I have some good news to...

Ryon

Heterogeneity in clinical molecular profiling: a case study

9 January 2014 Happy New Year. This week continues my Med Into Grad clinical exposure, and last night I was privileged to attend...

Ryon

N of 1 Study Insightful to Prostate Cancer Evolution, Therapy?

18 November 2013 Cancer is a microcosm of evolution, the most lethal versions of which are bestowed with an immense reservoir of genetic...

An Amazing Weekend with Pedal the Cause

(back to Science Blog) 30 October 2013 Pedal the Cause is many things. It’s a cancer research fundraiser. It’s a bike ride. It’s a...

Ryon

Could the liquid biopsy circumvent tumor heterogeneous hurdles?

24 October 2013 Nature magazine recently had a special Insight on tumor heterogeneity, complete with no less than six fantastic review...

On riding and ridding disease, motivations of medical researchers

27 September 2013 I’ve made another guest appearance in the award-winning science blog Beaker, offering meditations on medical research,...

Quantifying the Harms of Overdiagnosis?

17 September 2013 A central tenant of the Hippocratic Oath is “Do No Harm” and a recent article brought to my attention how few clinical...

Med Into Grad begins!

16 September 2013 I’m proud to announce that I’m taking part in the 2013-2014 Med Into Grad Initiative hosted by the UCSD School of...

The Future was Yesterday at the 25th Usha Mahajani Symposium on Cancer Genomics at the Salk Institut

10 September 2013 Yesterday I had the pleasure of attending the 25th Usha Mahajani Symposium at the Salk Institute. This year’s theme was...